Vivek N Prachand Selected Research

Thromboembolism

1/2017

Extended Duration Enoxaparin Decreases the Rate of Venous Thromboembolic Events after Radical Cystectomy Compared to Inpatient Only Subcutaneous Heparin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vivek N Prachand Research Topics

Disease

4	Weight Loss (Weight Reduction) 10/2023 - 10/2006
2	Obesity 01/2016 - 08/2010
2	Morbid Obesity 01/2016 - 08/2010
1	COVID-19 08/2020
1	Adenocarcinoma 01/2020
1	Neoplasms (Cancer) 01/2020
1	Venous Thromboembolism 01/2017
1	Hemorrhage 01/2017
1	Thromboembolism 01/2017
1	Diverticulum 12/2010
1	Gastroesophageal Reflux (GERD) 08/2010
1	Secondary Hyperparathyroidism 01/2009
1	Malnutrition (Nutritional Deficiencies) 01/2009
1	Vitamin D Deficiency 01/2009

Drug/Important Bio-Agent (IBA)

1	AntralIBA 01/2020
1	Trastuzumab (Herceptin)FDA Link 01/2020
1	Heparin (Liquaemin)FDA LinkGeneric 01/2017
1	Enoxaparin (Lovenox)FDA LinkGeneric 01/2017
1	Parathyroid Hormone (Parathormone)IBA 01/2009

Therapy/Procedure

4	Bariatric Surgery 10/2023 - 01/2009
3	Gastric Bypass (Roux-en-Y Gastric Bypass) 08/2010 - 10/2006
2	Therapeutics 01/2020 - 08/2010
2	Biliopancreatic Diversion 08/2010 - 10/2006
1	Operative Surgical Procedures 08/2020
1	Cystectomy 01/2017
1	Blood Transfusion (Blood Transfusions) 01/2017
1	Myotomy 12/2010
1	Fundoplication 08/2010
1	Gastrectomy 08/2010